Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Editor-in-Chief: Dr Roger M Pinder

1176-6328 (Print) - went to online only in 2009

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

This journal offers Accelerated Publication.

Articles:

Latest articles:

- 5 records -

Original Research

Second-Generation Long-Acting Injectable Antipsychotics: A Comprehensive Assessment of Effectiveness, Safety, and Cost

Ifteni P, Petric PS, Popa AV, Teodorescu A, Georgescu R, Manea MC

Neuropsychiatric Disease and Treatment 2026, 22:606817

Published Date: 20 June 2026

Original Research

Resting-State EEG Characteristics of Tardive Dyskinesia: Spectral and Network Connectivity Insights

Yan L, Xie B, Sun Y, Zheng M, Wang J, Li Y, Chen J, Zhou S, Yu X, Yuan J

Neuropsychiatric Disease and Treatment 2026, 22:595872

Published Date: 20 June 2026

Original Research

Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled Trial

Thase ME, Earley WR, Kozauer SG, Chen C, Lakkis H, Durgam S

Neuropsychiatric Disease and Treatment 2026, 22:594893

Published Date: 19 June 2026

Review

Mini-Review: Allicin as a Potential Neuroprotective Compound in Neurological Disorders

Tang WR, Chen KQ

Neuropsychiatric Disease and Treatment 2026, 22:621474

Published Date: 18 June 2026

Original Research

Modifying Neuropsychiatric and Motor Trajectories in Huntington’s Disease Through an Integrated Neurobehavioral Clinic Model

Khan S, Velez Figueroa L, Selvadurai C, Deshpande AR, Najmivarzaneh F, Lindbergh CA

Neuropsychiatric Disease and Treatment 2026, 22:605644

Published Date: 17 June 2026